WHO ICTRP trial
A prospective clinical study of neoantigen-loaded personalized dendritic cell…
ChiCTR2000040901 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000040901 |
|---|---|
| Public title | A prospective clinical study of neoantigen-loaded personalized dendritic cell vaccine in the treatment of spinal metastasis from kidney cancer |
| Scientific title | A prospective clinical study of neoantigen-loaded personalized dendritic cell vaccine in the treatment of spinal metastasis from kidney cancer |
| Primary sponsor | Shanghai Changzheng Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 0 |
| Countries | China |
| Conditions | spinal metastasis of kidney cancer |
| Interventions | DC vaccine immunotherapy group:DC vaccine immunotherapy;Traditional treatment group:Best treatment (chemotherapy or targeted drug therapy) |
| Registration date | Dec 14, 2020 |
| Target size | DC vaccine immunotherapy group:10;Traditional treatment group:10 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: